Association of body composition and physical activity with pain and function in knee osteoarthritis patients: a cross-sectional study DOI Creative Commons

Beibei Tong,

Hongbo Chen, Mengqi Wang

et al.

BMJ Open, Journal Year: 2024, Volume and Issue: 14(1), P. e076043 - e076043

Published: Jan. 1, 2024

The objective of this study is to delineate disparities between patients with knee osteoarthritis (KOA) based on obesity status, investigate the interplay among body composition, physical activity and pain/function in KOA conduct subgroup analyses focusing those obesity. Cross-sectional study. Residents eight communities Shijiazhuang, Hebei Province, China, were surveyed from March 2021 November 2021. 178 symptomatic aged 40 years or older included. primary outcome measure was pain, assessed using Western Ontario McMaster Universities Osteoarthritis Index-pain (WOMAC-P) scale. Secondary measures included function, evaluated through WOMAC-function (WOMAC-F) scale Five-Time-Sit-to-Stand Test (FTSST). Data analysis involved t-tests, Wilcoxon rank-sum tests, χ2 linear logistical regression analysis. Participants (n=178) 41-80 age (median: 65, P25-P75: 58-70), 82% female. Obese (n=103) had worse pain self-reported function (p<0.05). In general KOA, fat mass positively associated bilateral (β=1.21 (95% CI 0.03 0.15)), WOMAC-P scores (β=0.25 0.23 1.22)), WOMAC-F (β=0.28 0.35 1.29)) FTSST (β=0.19 0.42)), moderate-intensity low-intensity negatively (β=-0.80 -0.10 -0.01)) Skeletal Muscle Index (SMI) (β=-0.16 -0.66 -0.03)). obesity, SMI (β=-0.30 -3.94 -0.00)). Patients compared non-obese patients. Greater mass, lower muscle increased poor function. More skeletal improvement

Language: Английский

A Multifunctional Enzyme Cascade Catalytic Nanoplatform for Effective Synergistic Therapy of Rheumatoid Arthritis DOI Open Access
Wenyan Yu, Xinyun Wu, Ming Li

et al.

Advanced Functional Materials, Journal Year: 2025, Volume and Issue: unknown

Published: March 23, 2025

Abstract Insufficient oxygen supply and elevated levels of reactive species (ROS) in rheumatoid arthritis (RA) joints synergistically exacerbate inflammation accelerate disease progression. In this study, a hybrid nanoassembly composed superoxide dismutase (SOD) catalase (CAT) conjugated within single poly(ε‐caprolactone) (PCL) nanoparticle is developed for RA therapy. The synthesized (PSC) drives proximity‐dependent cascade reaction that efficiently scavenges ROS generates oxygen, thereby modulating the phenotype inflammatory macrophages synovium, significantly inhibiting secretion pro‐inflammatory cytokines, consequently alleviating inflammation. Furthermore, PSC functions as versatile drug delivery platform hydrophobic small‐molecule drugs. Iguratimod (IGU), an anti‐rheumatic with bone‐protective properties, incorporated into (PSC@IGU), which then loaded dissolvable microneedles (MNs) to enhance efficiency. Finally, PSC@IGU MNs demonstrate significant therapeutic effects mouse models by effectively improving joint hypoxia, synovial inflammation, preventing bone erosion. This study highlights potential PSC@IGU‐loaded treatment RA, indicating their promising ability bridge basic research clinical translation.

Language: Английский

Citations

1

Annexin A5 Derived from Cell-free Fat Extract Attenuates Osteoarthritis via Macrophage Regulation DOI Creative Commons
Zhuoxuan Jia, Bijun Kang,

Yushan Dong

et al.

International Journal of Biological Sciences, Journal Year: 2024, Volume and Issue: 20(8), P. 2994 - 3007

Published: Jan. 1, 2024

Osteoarthritis (OA) is a challenging degenerative joint disease to manage. Previous research has indicated that cell-free fat extract (CEFFE) may hold potential for OA treatment. This study investigated the role of Annexin A5 (AnxA5) within CEFFE in regulating macrophage polarization and protecting chondrocytes.

Language: Английский

Citations

6

Injectable Regenerated Silk Fibroin Micro/Nanosphere with Enhanced Permeability and Stability for Osteoarthritis Therapy DOI
Zixiang Wang,

Xueyang Yin,

Chenyang Zhuang

et al.

Small, Journal Year: 2024, Volume and Issue: 20(46)

Published: Aug. 5, 2024

Abstract In the therapy of early‐stage osteoarthritis, to accomplish full infiltration subchondral bone and cartilage, target osteoclast chondrocyte simultaneously remain challenges in biomaterials design. Herein, a novel hierarchical drug delivery system is introduced, with micrometer‐scale outer layer spheres composed regenerated silk fibroin, characterized by connected porous structure through n‐butanol fibroin combined emulsion route freezing method. The design effectively resists clearance from joint cavity, ensuring stable prolonged residence time within space. Additionally, incorporates phenylboronic acid‐enriched nanoparticles, stabilized chemical cross‐linking, which encapsulate isoliquiritin derived Glycyrrhiza uralensis. These nanoparticles facilitate complete penetration cartilage extracellular matrix, exhibit pH‐responsive behavior, neutralize reactive oxygen species, enable controlled release, thereby enhancing therapeutic efficacy. vitro vivo experiments both demonstrate that composite micro/nanospheres not only inhibit osteoclastogenesis loss osteophyte formation, but also mitigate chondrocytes apoptosis, reduce oxidative stress associated degeneration, ameliorate neuropathic hyperalgesia, underlying mechanisms being elucidated. study indicates such an injectable strategy combining organic Chinese medicine holds substantial promise for treatment early osteoarthritis.

Language: Английский

Citations

6

Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms DOI Creative Commons
Mengyuan Li, Fei Tian,

Jinling Guo

et al.

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: Aug. 11, 2023

Arthritis is a common degenerative disease of joints, which has become public health problem affecting human health, but its pathogenesis complex and cannot be eradicated. Coptis chinensis (CC) variety active ingredients, natural antibacterial anti-inflammatory drug. In which, berberine main effective ingredient, good therapeutic effects on rheumatoid arthritis (RA), osteoarthritis (OA), gouty (GA). RA, OA GA are the three most types arthritis, relevant not clear. Therefore, molecular mechanism prevention treatment key issues to paid attention in clinical practice. general, berberine, palmatine, coptisine, jatrorrhizine, magnoflorine jatrorrhizine hydrochloride CC play role treating by regulating Wnt1/β-catenin PI3K/AKT/mTOR signaling pathways. this review, targets were expounded, we have further explained potential AHR, CAV1, CRP, CXCL2, IRF1, SPP1, IL-17 pathway provide new idea for CC.

Language: Английский

Citations

12

Association of body composition and physical activity with pain and function in knee osteoarthritis patients: a cross-sectional study DOI Creative Commons

Beibei Tong,

Hongbo Chen, Mengqi Wang

et al.

BMJ Open, Journal Year: 2024, Volume and Issue: 14(1), P. e076043 - e076043

Published: Jan. 1, 2024

The objective of this study is to delineate disparities between patients with knee osteoarthritis (KOA) based on obesity status, investigate the interplay among body composition, physical activity and pain/function in KOA conduct subgroup analyses focusing those obesity. Cross-sectional study. Residents eight communities Shijiazhuang, Hebei Province, China, were surveyed from March 2021 November 2021. 178 symptomatic aged 40 years or older included. primary outcome measure was pain, assessed using Western Ontario McMaster Universities Osteoarthritis Index-pain (WOMAC-P) scale. Secondary measures included function, evaluated through WOMAC-function (WOMAC-F) scale Five-Time-Sit-to-Stand Test (FTSST). Data analysis involved t-tests, Wilcoxon rank-sum tests, χ2 linear logistical regression analysis. Participants (n=178) 41-80 age (median: 65, P25-P75: 58-70), 82% female. Obese (n=103) had worse pain self-reported function (p<0.05). In general KOA, fat mass positively associated bilateral (β=1.21 (95% CI 0.03 0.15)), WOMAC-P scores (β=0.25 0.23 1.22)), WOMAC-F (β=0.28 0.35 1.29)) FTSST (β=0.19 0.42)), moderate-intensity low-intensity negatively (β=-0.80 -0.10 -0.01)) Skeletal Muscle Index (SMI) (β=-0.16 -0.66 -0.03)). obesity, SMI (β=-0.30 -3.94 -0.00)). Patients compared non-obese patients. Greater mass, lower muscle increased poor function. More skeletal improvement

Language: Английский

Citations

5